Detalhe da pesquisa
1.
From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.
Clin Immunol
; 176: 87-93, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108364